India's Kerala State Health Department announces lung health project to address TB, other respiratory diseases

NewsGuard 100/100 Score

India's Kerala state in November plans to implement the Practical Approach to Lung Health Project, which aims to examine the prevalence of tuberculosis and other lung diseases in the region, a health department official said recently, The Hindu reports.

The official announcement of the project will occur during the International Union Against TB and Lung Disease's Conference of the South East Asia Region, which is scheduled for Sept. 8 to Sept. 10 in New Delhi.

The project will work with India's Revised National TB Control Program and the Kerala State Department of Health and Family Welfare, with additional support from the World Health Organization, the National Rural Health Mission, and the community medicine and respiratory medicine departments of medical colleges in the Thiruvananthapuram and Kozhikode districts. According to The Hindu, the TB detection rate in Kerala is 68%, below India's national rate of 70%. In addition, Kerala screens a higher proportion of the population for TB, with 250 to 300 TB screenings per 100,000 people, compared with the national average of 150 TB screenings per 100,000 people. Health and TB experts have not determined the factors affecting the low detection rate in Kerala, The Hindu reports.

Kerala will be the first state to implement the lung health project, which also will examine the prevalence of non-TB respiratory diseases, The Hindu reports (Radhakrishnan, The Hindu, 9/1).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Alarmin molecule identified as therapeutic target for allergic respiratory diseases